Where Chinese Investors Meet Global Investment News and Opportunities

中國投資者探索環球投資新聞及機遇

Invitrocue signs technology development agreement to include indications for multiple breast cancer subtypes

Invitrocue signs technology development agreement to include indications for multiple breast cancer subtypes

Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the signing of a new technology development agreement with the Shanghai Institute of Biochemistry and Cell Biology (SIBCB), Chinese...

Read more
Heidelberg Pharma Receives Milestone Payment From Partner Link Health

Heidelberg Pharma Receives Milestone Payment From Partner Link Health

Heidelberg Pharma AG (FSE: WL6) announced today that it has received a milestone payment from its cooperation partner Link Health Co., Guangzhou, China. The transaction follows the approval of the Chinese National Medical Product Administration...

Read more
Bio-Thera Starts Global Phase III Trial of Arthritis-targeted Biosimilar

Bio-Thera Starts Global Phase III Trial of Arthritis-targeted Biosimilar

Bio-Thera Solutions of Guangzhou has begun dosing rheumatoid arthritis patients in a global Phase III trial of its biosimilar to Genentech’s RoActemra®. Bio-Thera’s BAT1806 is one of four Bio-Thera candidates in Phase III trials. The...

Read more
WeChat Pay launches new service with Paris department store

WeChat Pay launches new service with Paris department store

China’s leading mobile payment supplier, Wechat Pay, has teamed with Paris-based department Le BHV Marais, to help European businesses connect with growing Chinese tourists. WeChat Pay on Wednesday introduced a smart and sustainable...

Read more
Lianluo Smart Expands Its Wearable Sleep Diagnostic Products into More Than 20 Medical Examination Centers in Beijing

Lianluo Smart Expands Its Wearable Sleep Diagnostic Products into More Than 20 Medical Examination Centers in Beijing

Lianluo Smart Limited (“Lianluo Smart” or the “Company”) (Nasdaq: LLIT), a China based professional smart service and products provider, today announced its wearable sleep diagnostic products and cloud-based service from...

Read more
Immunochina Raises $20.4 Million USD in Series C Financing

Immunochina Raises $20.4 Million USD in Series C Financing

Beijing-based Immunochina Pharmaceuticals today announced the closing of its $140 million RMB Series C financing (approximately $20.4 million in US Dollars). This financing will enable the company to expand its GMP-grade manufacturing...

Read more
I-Mab Approved to Start US Trials of Immunotherapy for Solid Tumors

I-Mab Approved to Start US Trials of Immunotherapy for Solid Tumors

Shanghai’s I-Mab Biopharma announced that its novel CD73 antibody (TJD5), an immunotherapy, was cleared to start Phase I trials in the US. TJD5, the second I-Mab candidate to begin US clinical trials, will be tested in patients with...

Read more
Samsung Bioepis’ First Cancer Biosimilar Approved by the FDA

Samsung Bioepis’ First Cancer Biosimilar Approved by the FDA

The U.S. Food and Drug Administration (FDA) approved South Korea’s Samsung Bioepis’ Ontruzant (trastuzumab-dttb), a biosimilar to Genentech’s Herceptin (trastuzumab). Samsung Bioepis is a joint venture between Samsung Biologics and Biogen. The...

Read more
AOTI Enters Into Multi-Million USD Strategic Relationship for Chinese Market

AOTI Enters Into Multi-Million USD Strategic Relationship for Chinese Market

AOTI Inc. announced today that it has entered into a major strategic relationship with a leading Chinese medical company, Nanning Xinzizhu Trading Co.,Ltd, for distribution of its patented Topical Wound Oxygen (TWO2) therapy wound healing...

Read more
iKang Healthcare Closes $1.4 Billion Privatization, Led by Alibaba

iKang Healthcare Closes $1.4 Billion Privatization, Led by Alibaba

iKang Healthcare, a private China healthcare chain, completed a $1.4 billion privatization backed by an Alibaba investment arm and Yunfeng Capital, a private equity firm co-founded by Alibaba’s Jack Ma and David Yu. The company, which seems...

Read more
CVS, Walmart reach an agreement on a pharmacy contract after impasse

CVS, Walmart reach an agreement on a pharmacy contract after impasse

CVS Health and Walmart said the world’s largest retailer would remain part of CVS’s network for commercial and Medicaid pharmacy customers. The deal broke a contract impasse CVS disclosed earlier this week. Financial terms of the new...

Read more
J&J and Apple Team up for AFib Program With Apple Watch

J&J and Apple Team up for AFib Program With Apple Watch

Janssen Pharmaceutical and Apple have teamed up to determine if a new app for the Apple Watch, which has a built-in electrocardiogram can improve the health of more than 30 million people with atrial fibrillation (AFib), a condition that can lead...

Read more
Do NOT follow this link or you will be banned from the site!